Diabetes Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Diabetes Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Heart Disease Therapy
Milestone II Registry reaffirms positive safety outcomes stent system
September 27th, 2004
Angiotech Pharmaceuticals, Inc.'s, (ANPI, ANP) corporate partner, Boston Scientific, announced 6-month clinical findings from the European component of its Milestone II Registry. Boston Scientific said it has enrolled nearly 3700 patients worldwide in the registry, which has been designed to assess physician usage patterns and evaluate outcome data for the Taxus Express(2) paclitaxel-eluting coronary stent system in "real world" patients. The Milestone II registry has enrolled 1907 patients in Europe alone, where 118 centers were closely monitored. Analysis of the data was presented by Boston Scientific at the European Society of Cardiology's (ESC)...
Source: Diabetes Week (2004-09-27)
|
